AR032519A1 - COMPOUNDS - Google Patents

COMPOUNDS

Info

Publication number
AR032519A1
AR032519A1 ARP020100273A ARP020100273A AR032519A1 AR 032519 A1 AR032519 A1 AR 032519A1 AR P020100273 A ARP020100273 A AR P020100273A AR P020100273 A ARP020100273 A AR P020100273A AR 032519 A1 AR032519 A1 AR 032519A1
Authority
AR
Argentina
Prior art keywords
compounds
relates
present
methylbenzylamino
imidazo
Prior art date
Application number
ARP020100273A
Other languages
Spanish (es)
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of AR032519A1 publication Critical patent/AR032519A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invencion se refiere a nuevas formas cristalinas de la sal de mesilato de 2,3- dimetil-8-(2-etil-6-metilbencilamino)-imidazo[1,2-a]piridina-6-carboxamida. Además, la presente invencion se refiere también al uso de dichos compuestos para el tratamiento de desordenes gastrointestinales, a las composiciones farmacéuticas que los contienen y a los procedimientos para obtenerlos.The present invention relates to novel crystalline forms of the 2,3-dimethyl-8- (2-ethyl-6-methylbenzylamino) -imidazo [1,2-a] pyridine-6-carboxamide mesylate salt. In addition, the present invention also relates to the use of said compounds for the treatment of gastrointestinal disorders, to the pharmaceutical compositions containing them and to the methods for obtaining them.

ARP020100273A 2001-02-01 2002-01-25 COMPOUNDS AR032519A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0100296A SE0100296D0 (en) 2001-02-01 2001-02-01 New compounds

Publications (1)

Publication Number Publication Date
AR032519A1 true AR032519A1 (en) 2003-11-12

Family

ID=20282798

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP020100273A AR032519A1 (en) 2001-02-01 2002-01-25 COMPOUNDS

Country Status (3)

Country Link
AR (1) AR032519A1 (en)
SE (1) SE0100296D0 (en)
WO (1) WO2002060441A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2506027A1 (en) 2002-11-19 2004-06-03 Altana Pharma Ag 8-substituted imidazopyridines
EP1682133A1 (en) 2003-11-03 2006-07-26 AstraZeneca AB Imidazo 1,2-a pyridine derivatives for the treatment of silent gastro-esophageal reflux
SE0303451D0 (en) 2003-12-18 2003-12-18 Astrazeneca Ab New compounds
WO2007043939A1 (en) * 2005-10-07 2007-04-19 Astrazeneca Ab Novel crystalline form of 3,5-dibromo-n- [(2s)-2-(-4-fluorophenyl)-4-(3-morpholin-4-ylazetidin-1-yl)butyl] -n-methylbenzamide, modification a

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9801526D0 (en) * 1998-04-29 1998-04-29 Astra Ab New compounds

Also Published As

Publication number Publication date
WO2002060441A1 (en) 2002-08-08
SE0100296D0 (en) 2001-02-01

Similar Documents

Publication Publication Date Title
ECSP088413A (en) PREPARATION AND USE OF TETRAHYDROPIRROLO DERIVATIVES [3,2-C] PIRIDIN-4-ONA FOR THE TREATMENT OF OBESITY, PSYCHIATRIC AND NEUROLOGICAL DISORDERS
HN2002000275A (en) DERIVATIVES OF 1.8 NAFTIRIDINE AND ITS USE FOR THE TREATMENT OF DIABETES AND RELATED DISORDERS
UY28376A1 (en) THERAPEUTIC AGENTS
UY27740A1 (en) NEW COMPOUNDS
CL2003002287A1 (en) COMPOUNDS DERIVED FROM TIENO [3,2-b] -PIRIDINA-6-CARBONITRILOS AND TIENEO [2,3-b] -PIRIDINA-5-CARBONITRILS, PHARMACEUTICAL COMPOSITION, PROCEDURE OF PREPARATION AND INTERMEDIARY COMPOUNDS, AND THEIR USE IN THE TREATMENT OF CANCER, APOPLEJIA, OSTEOPOROSIS
AR052447A1 (en) 1- (2-METIPROPIL) ETANSULFONATE -1H-IMIDAZO [4,5-C] [1,5] NAFTIRIDIN-4- AMINA AND 1- (2- METIPROPIL) -1H-IMIDAZO [4,5-C ] [1,5] NAFTIRIDIN-4-AMINA
UY28510A1 (en) CHEMICAL COMPOUNDS
AR048912A1 (en) ANTI-NOGO IMMUNOGLOBULINS
CR6726A (en) AZAPOLICICLIC COMPOUNDS CONDENSED WITH ARILO
UY29781A1 (en) DIAZASPIRO SUBSTITUTE COMPOUNDS, PHARMACEUTICALLY ACCEPTABLE SALTS, PHARMACEUTICAL COMPOSITIONS CONTAINING THE COMPOUNDS OR SALTS, PREPARATION METHODS AND USES
CR9834A (en) [1,8] NAFTIRIDIN-2-ONAS AND RELATED COMPOUNDS FOR THE TREATMENT OF EZQUIZOPHRENIA
WO2006107853A3 (en) Pyrazolopyridine-1,4-diamines and analogs thereof
AR054122A1 (en) PIRIDO [2,3-D] USEFUL PYRIMIDES AS HCV INHIBITORS, AND METHODS FOR THE PREPARATION OF THE SAME
HN2002000154A (en) AZAINDOLS
CY1113047T1 (en) NEW Crystalline and Amorphous Form of a Triazolo (4,5-D) Pyrimidine Compound
EA200700144A1 (en) PYRIDOPYRIMIDINE DERIVATIVES, THEIR RECEIVING, THEIR APPLICATION IN THERAPY
HUP0402270A2 (en) [1,2,4]triazolo[1,5-c]pyrimidin-5-yl-amines as adenosine a2a receptor antagonists and pharmaceutical compositions containing them
CR9643A (en) DERIVATIVES OF N- (ARILALQUIL) -1H-PIRROLOPIRIDINA-2-CARBOXAMIDAS, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS
AR028250A1 (en) IMIDAZO [1,5-A] -PIRIDO [3,2-E] -PIRAZINONAS, THE USE OF SUCH COMPOUNDS AND ITS SALTS FOR THE PREPARATION OF MEDICINES AND THE MEDICINES SO PREPARED
HN2002000365A (en) LACTAMAS AS TAQUIQUININE ANTAGONISTS
GT200500340A (en) DERIVATIVES OF OCTAHIDROPIRROLO [3,4-C] PIRROL
UY28377A1 (en) THERAPEUTIC AGENTS
SI1869038T1 (en) SUBSTITUTED 5,6,7,8-TETRAHYDRO-IMIDAZO?á1,2-A?åPYRIDIN-2-YLAMINE COMPOUNDS AND THEIR USE FOR PRODUCING DRUGS
DOP2002000390A (en) SALT CITRATE 5.8 14-HIEZATETRACICLO [10.3.1.0 2.11. 0.4.9] HEXADECA-2 (11), 3,5,8,9, PENTAENE AND PHARMACEUTICAL COMPOSITIONS OF THE SAME
UY29741A1 (en) SALTS OF 1,5- DIARIL PIRAZOL-3-CARBOXAMIDS, PREPARATION PROCESSES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, APPLICATIONS AND METHODS OF USE.

Legal Events

Date Code Title Description
FB Suspension of granting procedure